Ariston Holding Valuation
Is 0ABE undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0ABE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0ABE (€3.75) is trading above our estimate of fair value (€2.99)
Significantly Below Fair Value: 0ABE is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0ABE?
Key metric: As 0ABE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 0ABE's PE Ratio? | |
|---|---|
| PE Ratio | 22.3x |
| Earnings | €57.70m |
| Market Cap | €1.29b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.7x |
| Enterprise Value/EBITDA | 8.1x |
| PEG Ratio | 0.5x |
Price to Earnings Ratio vs Peers
How does 0ABE's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 24.2x | ||
FAN Volution Group | 25.9x | 12.1% | UK£1.1b |
GEN Genuit Group | 43.2x | 30.7% | UK£1.0b |
JHD James Halstead | 19.2x | 4.1% | UK£796.1m |
NXR Norcros | 8.7x | -1.2% | UK£232.5m |
0ABE Ariston Holding | 22.3x | 43.1% | €1.3b |
Price-To-Earnings vs Peers: 0ABE is good value based on its Price-To-Earnings Ratio (22.3x) compared to the peer average (24.2x).
Price to Earnings Ratio vs Industry
How does 0ABE's PE Ratio compare vs other companies in the European Building Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 0ABE is expensive based on its Price-To-Earnings Ratio (22.3x) compared to the European Building industry average (20x).
Price to Earnings Ratio vs Fair Ratio
What is 0ABE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 22.3x |
| Fair PE Ratio | 35.4x |
Price-To-Earnings vs Fair Ratio: 0ABE is good value based on its Price-To-Earnings Ratio (22.3x) compared to the estimated Fair Price-To-Earnings Ratio (35.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €3.75 | €4.84 +29.2% | 11.8% | €5.80 | €4.00 | n/a | 9 |
| Nov ’25 | €3.89 | €4.82 +24.0% | 12.8% | €5.80 | €3.70 | n/a | 9 |
| Oct ’25 | €4.39 | €5.17 +17.6% | 18.7% | €7.00 | €3.70 | n/a | 9 |
| Sep ’25 | €4.18 | €5.40 +29.1% | 21.6% | €7.00 | €3.80 | n/a | 10 |
| Aug ’25 | €3.73 | €5.57 +49.2% | 18.6% | €7.00 | €4.00 | n/a | 10 |
| Jul ’25 | €3.81 | €6.30 +65.5% | 13.5% | €8.00 | €5.00 | n/a | 10 |
| Jun ’25 | €4.67 | €6.67 +42.9% | 14.0% | €8.40 | €5.40 | n/a | 10 |
| May ’25 | €4.84 | €6.95 +43.7% | 12.9% | €8.40 | €5.60 | n/a | 10 |
| Apr ’25 | €5.21 | €7.39 +42.0% | 13.0% | €9.00 | €5.70 | n/a | 10 |
| Mar ’25 | €5.49 | €7.94 +44.8% | 11.7% | €9.00 | €6.50 | n/a | 10 |
| Feb ’25 | €6.04 | €8.15 +35.0% | 12.2% | €9.40 | €6.50 | n/a | 10 |
| Jan ’25 | €6.25 | €8.43 +34.9% | 19.1% | €12.00 | €6.50 | n/a | 9 |
| Dec ’24 | €5.72 | €8.79 +53.8% | 22.8% | €12.20 | €6.50 | n/a | 9 |
| Nov ’24 | €5.32 | €9.37 +76.1% | 23.9% | €12.20 | €6.50 | €3.89 | 9 |
| Oct ’24 | €6.20 | €10.24 +65.4% | 15.5% | €12.20 | €7.70 | €4.39 | 9 |
| Sep ’24 | €7.11 | €11.36 +59.8% | 12.0% | €14.00 | €9.50 | €4.18 | 9 |
| Aug ’24 | €8.52 | €12.06 +41.5% | 10.4% | €14.00 | €10.20 | €3.73 | 9 |
| Jul ’24 | €9.53 | €12.16 +27.6% | 10.1% | €14.00 | €10.20 | €3.81 | 9 |
| Jun ’24 | €10.16 | €12.16 +19.6% | 10.1% | €14.00 | €10.20 | €4.67 | 9 |
| May ’24 | €10.52 | €11.92 +13.3% | 10.5% | €14.00 | €10.00 | €4.84 | 9 |
| Apr ’24 | €9.26 | €11.69 +26.2% | 11.3% | €14.00 | €10.00 | €5.21 | 8 |
| Mar ’24 | n/a | €11.16 0% | 10.3% | €13.00 | €9.80 | €5.49 | 7 |
| Feb ’24 | €9.54 | €11.10 +16.4% | 11.0% | €13.00 | €9.80 | €6.04 | 6 |
| Jan ’24 | €9.55 | €10.81 +13.1% | 14.8% | €13.00 | €8.25 | €6.25 | 6 |
| Dec ’23 | €9.23 | €10.97 +18.8% | 15.6% | €13.00 | €8.25 | €5.72 | 5 |
| Nov ’23 | n/a | €11.13 0% | 14.6% | €13.00 | €8.25 | €5.32 | 5 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Aalberts
€3.8b
Offers mission-critical technologies for aerospace, automotive, building, and maritime sectors.
0NX1
€34.71
7D
0.7%
1Y
-3.0%
Renold
UK£106.4m
Engages in the manufacture and sale of high precision engineered products and solutions in the United Kingdom, rest of Europe, the United States, Canada, Australasia, China, India, and internationally.
RNO
UK£0.54
7D
-1.8%
1Y
59.6%
Per Aarsleff Holding
DKK 7.4b
Engages in the construction and maintenance of infrastructure and building structures of society in Denmark and internationally.
0REQ
DKK 410.50
7D
-1.8%
1Y
27.0%